Diabetes - Publications - Faculty & Research

13 Dec 2022
News

The First Five Years: Christine Keung and Reggie Smith

operations at a venture-backed telemedicine startup that treats chronic conditions like diabetes and obesity and makes care accessible to patients in all 50 states, including West Virginia. What did you enjoy most about your HBS... View Details

23 Dec 2014
First Look

First Look: December 23

care costs. Physicians often failed to engage patients in preventative care, which many believed would help combat the rising costs of treating chronic conditions. Diabetes and hypertension, in particular, afflicted many developed nations... View Details

Keywords: Carmen Nobel

01 Mar 2009
News

Model Patient

would provide the specialists and the full range of necessary care for patients suffering from chronic diseases or disabilities such as diabetes or bad backs. Rather than leaving it to the patient to search for a specialist in one area,... View Details

Keywords: Garry Emmons; Health, Social Assistance

20 Dec 2022
News

Singing to the Corn

Nation in health care, with a focus on preventing diabetes in indigenous populations. "I quickly realized that business alone was not enough to reverse the dysfunction of some tribal economies," says Keen. Earlier, he'd experienced the... View Details

01 Dec 2001
News

Reaching Out

particularly interesting to Mukhtar, based on his experience as a physician in Nigeria, where medical treatment is essentially unavailable or unaffordable for much of the population. "One cohort in Singapore that is highly susceptible to hypertension and View Details

Keywords: Garry Emmons and Julia Hanna; Health, Social Assistance

07 Apr 2009
First Look

First Look: April 7, 2009

http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=109057 Amylin Pharmaceuticals: Diabetes and Beyond Harvard Business School Case 809-011 Ginger Graham, CEO of Amylin Pharmaceuticals, joined the company with the expectation... View Details

Keywords: Martha Lagace

15 Jan 2013
First Look

First Look: January 15

KnoopHarvard Business School Case 813-091 Amylin Pharmaceuticals brought two first-in-class diabetes drugs to market, Byetta and Symlin, in 2005, which were sold in over 80 countries with $650.7 million in sales by 2011. However, the... View Details

Keywords: Sean Silverthorne

01 Dec 2016
News

Alumni Books of 2016

unprecedented rates. Diabetes rates have boomed. Online data thefts have surged. Urbanization and waste have soared. What is happening? Is it globalization? Or is something much deeper taking place, something that the world had never... View Details

Publications